Scopus Eşleşmesi Bulundu
24
Atıf
13
Cilt
🔓
Açık Erişim
Özet
Background: Serum apoptotic cytokeratine 18 neoepitope M30 (CK-18 M30) and matrix metalloproteinase 2 (MMP-2) have been popular markers for detecting liver fibrosis in recent years. CK-18 is a major intermediate filament protein in liver cells and one of the most prominent substrates of caspases during hepatocyte apoptosis. MMP-2 plays an important role in tissue remodeling and repairing processes during physiological and pathological states. Objectives: The objective of this study was to investigate the significance of CK-18 M30 and MMP-2 levels for clinical use in patients with chronic hepatitis B (CHB), as well as their sensitivity in determining cirrhotic patients. Patients and Methods: This study included 189 CHB patients and 51 healthy controls. A modified Knodell scoring system was used to determine the fibrosis level in chronic hepatitis B patients. CK-18 M30 levels were determined with an M30-Apoptosense ELISA assay. MMP-2 levels were determined with the ELISA assay. Results: The study group consisted of 132 (69.8%) males and 57 (30.2%) females, and the control group consisted of 25 males (49.0%) and 26 females (51%). Patients' CK-18 M30 levels were higher than values of the control group (308 [1-762] vs. 168 [67-287], P=0.001). Serum MMP-2 levels were found to be statistically higher in the patient group with respect to the controls (3.0 [1.1-6.8] vs. 2.0 [1.2-3.4], P=0.001). The highest serum CK-18 M30 and MMP-2 levels were measured in patients with cirrhosis. Serum apoptotic CK-18 M30 levels positively correlated with advanced age, fibrosis stage, serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels (P= 0.001, 0.033, 0.001, and 0.001, respectively). Serum MMP-2 levels positively correlated with fibrosis stage, serum ALT, and AST levels (P= 0.001, 0.001, and 0.001, respectively). Conclusions: Our study indicated that CK-18 M30 and MMP-2 levels were higher in CHB patients compared to healthy controls and they were in association with significant hepatic fibrosis, especially cirrhosis. © 2013, Kowsar Corp.
Web of Science Eşleşmesi Bulundu
23
WoS Atıf
13
Cilt
Article
Belge Türü
Kaynak: HEPATITIS MONTHLY
Anahtar Kelimeler (WoS)
Havuzumuzdaki Atıflar 0
Bu makaleye, sistemimizdeki Scopus veritabanında bulunan 0 makale atıf yapmıştır. Scopus genel atıf sayısı: 24.
Bu makaleye, kendi Scopus havuzumuzdaki başka bir makaleden atıf kaydı bulunmuyor.
Scimago Dergi Bilgisi
Otomatik ISSN Eşleştirmesi
2013 yılı verileri
Hepatitis Monthly
Q3
SJR Quartile
0,449
SJR Skoru
48
H-Index
🔓
Açık Erişim
Kategoriler: Hepatology (Q3) · Infectious Diseases (Q3)
Alanlar: Medicine
Ülke: Netherlands
· Brieflands
Bu bilgiler makale yılına göre Scimago veritabanından ISSN eşleştirmesiyle otomatik getirilmektedir.
Dergi sıralama verileri Scimago'nun ilgili yılı baz alınmaktadır.
Anahtar Kelimeler
WoS |
Bir kelimeye tıklayıp ilgili kaynaktaki yayınları görün.
Makale Bilgileri
Dergi
Hepatitis Monthly
ISSN
1735-3408
Yıl
2013
/ 6. ay
Cilt / Sayı
13
/ 6
Makale Türü
Özgün Makale
Hakemlik
Hakemli
Endeks
SCI-Expanded
Yayın Dili
İngilizce
Ülke
İRAN
Uluslararası
Kapsam
Uluslararası
Toplam Yazar
7 kişi
Erişim Türü
Elektronik
Alan
Sağlık Bilimleri Temel Alanı-
Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji
YÖKSİS Yazar Kaydı
Yazar Adı
Sumer Sua, Aktug Demir Nazlim, Kolgelier Servet, Inkaya Ahmet Cagkan, Arpaci Abdullah, Demir Lutfi Saltuk, Ural Onur